Outset Medical, Inc.
NASDAQ:OM
11.58 (USD) • At close April 25, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 113.689 | 130.376 | 115.375 | 102.602 | 49.935 | 15.078 | 2.007 |
| Kosten van de omzet
| 75.125 | 101.376 | 97.542 | 94.994 | 62.972 | 32.88 | 8.122 |
| Brutowinst
| 38.564 | 29 | 17.833 | 7.608 | -13.037 | -17.802 | -6.115 |
| Brutowinstmarge
| 0.339 | 0.222 | 0.155 | 0.074 | -0.261 | -1.181 | -3.047 |
| Onderzoek- en ontwikkelingskosten
| 38.397 | 57.307 | 48.855 | 36.741 | 28.85 | 23.327 | 22.916 |
| Algemene en administratieve kosten
| 43.498 | 45.231 | 40.515 | 36.316 | 30.512 | 8.919 | 6.253 |
| Verkoop- en marketingkosten
| 70.044 | 96.232 | 89.482 | 65.07 | 45.068 | 20.259 | 11.279 |
| Verkoop-, algemene en administratieve kosten
| 113.542 | 141.463 | 129.997 | 101.386 | 75.58 | 29.178 | 17.532 |
| Overige kosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bedrijfskosten
| 151.939 | 198.77 | 178.852 | 138.127 | 104.43 | 52.505 | 40.448 |
| Bedrijfsresultaat
| -113.375 | -169.77 | -161.019 | -130.519 | -117.467 | -70.307 | -46.563 |
| Bedrijfsresultaat ratio
| -0.997 | -1.302 | -1.396 | -1.272 | -2.352 | -4.663 | -23.2 |
| Totaal overige inkomsten en kosten netto
| -14.11 | -2.504 | -1.642 | -1.217 | -4.025 | 2.028 | -3.192 |
| Inkomen voor belasting
| -127.485 | -172.274 | -162.661 | -131.736 | -121.492 | -68.279 | -49.755 |
| Inkomen voor belasting ratio
| -1.121 | -1.321 | -1.41 | -1.284 | -2.433 | -4.528 | -24.791 |
| Belastingkosten
| 0.491 | 0.523 | 0.295 | 0.199 | -0.794 | 0.02 | 0.025 |
| Nettowinst
| -127.976 | -172.797 | -162.956 | -131.935 | -120.698 | -68.299 | -49.78 |
| Nettowinstmarge
| -1.126 | -1.325 | -1.412 | -1.286 | -2.417 | -4.53 | -24.803 |
| WPA (Winst Per Aandeel)
| -2.46 | -3.48 | -3.38 | -2.89 | -2.83 | -1.61 | -1.65 |
| Verwaterde WPA
| -2.46 | -3.48 | -3.38 | -2.89 | -2.83 | -1.61 | -1.65 |
| EBITDA
| -97.886 | -153.789 | -152.812 | -124.859 | -114.846 | -62.087 | -43.622 |
| EBITDA ratio
| -0.861 | -1.18 | -1.324 | -1.217 | -2.3 | -4.118 | -21.735 |